Thomas Hallam, outgoing Palisade Bio CEO

An­oth­er biotech CEO de­parts, leav­ing be­hind few em­ploy­ees for PhI­II

A month af­ter lay­ing off 20% of its em­ploy­ees, Pal­isade Bio’s CEO is al­so out the door. Thomas Hal­lam hit the ex­it on Mon­day and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.